Overview

Information. Access. Accountability.

Thomas K Equels, M.S., J.D.

Executive Vice Chairman, Chief Executive Officer & President

About Tom

December 10, 2025 –

The Unmet Need in Pancreatic Cancer

August 21, 2025 –

Sharpening Our Focus:
AIM’s Lead Program in Pancreatic Cancer

July 29, 2024 –

Early Stage Triple Negative
Breast Cancer

July 3, 2024 –

Corporate and Clinical Update

April 25, 2024 –

Metastatic Pancreatic Cancer

April 18, 2024 –
Locally Advanced Pancreatic Adenocarcinoma

April 11, 2024 –
Top-line Interim Data from Recurrent Ovarian Cancer Study

March 22, 2024 –
Virtual Investor Lunch Break:
The AIM Opportunity

March 20, 2024 –
Ovarian Cancer

March 13, 2024 –
Oncology Overview

March 7, 2024 –
Welcome to the AIM CEO Corner

Topics For Tom

Suggest

Our Team